前哨淋巴结活检时机独立预测临床I-II期黑色素瘤患者的无病生存和总生存:意大利黑色素瘤协作组(IMI)多中心研究
多因素分析显示,SNB延迟与更好的DFS(aHR 0.98, 95%CI 0.97-0.99, p<0.001)和OS(aHR 0.98, 95%CI 0.97-0.99, p=0.001)相关;在SNB阴性患者中,延迟SNB(至少32天)的DFS和OS获益显著,而SNB阳性患者中无显著差异。研究不支持严格的时间间隔。
要点
- SNB延迟与临床I-II期黑色素瘤患者更好的DFS和OS独立相关。
- SNB阴性患者中,原发切除后至少32天行SNB与显著改善的DFS和OS相关。
- SNB阳性患者中,早期与延迟SNB的DFS和OS无显著差异。
核心结论
- SNB时机是临床I-II期黑色素瘤患者DFS和OS的独立预测因素,延迟SNB与更好生存相关,尤其在SNB阴性患者中。
- 研究结果不支持对SNB设定严格的时间间隔。
研究设计与样本
- 采用多因素Cox回归分析基线特征和SNB时间间隔与DFS和OS的关系。
主要发现
- 全人群多因素分析(调整年龄、性别、Breslow厚度、部位、溃疡和SNB状态)显示,SNB延迟与更好的DFS(aHR 0.98, 95%CI 0.97-0.99, p<0.001)和OS(aHR 0.98, 95%CI 0.97-0.99, p=0.001)相关。
- SNB阴性患者中,延迟SNB(至少32天)与更好的DFS(aHR 0.70, 95%CI 0.63-0.79, p<0.001)和OS(aHR 0.69, 95%CI 0.61-0.78, p<0.001)相关。
- SNB阳性患者中,早期与延迟SNB的DFS(aHR 0.96, 95%CI 0.84-1.09, p=0.534)和OS(aHR 0.94, 95%CI 0.81-1.08, p=0.374)无显著差异。
临床怎么用
- 临床I-II期黑色素瘤患者行SNB无需严格限定时间间隔,可减少高紧急转诊。
- SNB阴性患者中延迟SNB(至少32天)与更优生存相关,可用于患者咨询。
- SNB阳性患者中SNB时机对生存无显著影响,治疗决策应优先考虑其他因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sentinel lymph node biopsy (SNB) still remains a key procedure to appropriately stage melanoma patients and to select those who are candidate to novel treatments with immunotherapy and targeted therapy in the adjuvant setting. The impact of timing of SNB on disease-free survival (DFS) and overall survival (OS) is still unclear. MATERIAL AND METHODS: The study was conducted at 6 Italian Melanoma Intergroup (IMI) centres and included 8953 consecutive clinical stage I-II melanoma patients who were diagnosed, treated, and followed up between November 1997 and March 2018. All patients were prospectively included in dedicated IMI database. Multivariable Cox regression analyses were performed to investigate how baseline characteristics and time interval until SNB are related to DFS and OS. RESULTS: Considering the whole population, at multivariable analysis, after adjusting for age, gender, Breslow thickness, site, ulceration, and the SNB status, a delay in the timing of SNB was associated with a better DFS (adjusted hazard ratio [aHR, delayed versus early SNB] 0.98, 95% confidence interval [CI] 0.97-0.99, p < 0.001) and OS (aHR 0.98, 95% CI 0.97-0.99, p = 0.001). Specifically, in patients with a negative SNB status, a beneficial impact of delayed SNB (i.e. at least 32 days after primary excision) was confirmed for DFS (aHR 0.70, 95%CI 0.63-0.79, p < 0.001) and OS (aHR 0.69, 95%CI 0.61-0.78, p < 0.001), whereas in those with a positive SNB status, DFS (aHR 0.96, 95%CI 0.84-1.09, p = 0.534) and OS (aHR 0.94 95%CI 0.81-1.08, p = 0.374) were not significantly different in patients with early or delayed SNB. CONCLUSIONS: Our study does not support a strict time interval for SNB. These results may be useful for national guidelines, for counselling patients and reducing the number of high urgency referrals.
引用
- Mandalà M, Galli F, Patuzzo R, et al. Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI). Eur J Cancer. 2020. PMID: 32739767. doi:10.1016/j.ejca.2020.07.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。